Immunohistochemistry (IHC) staining of colon cancer tissue removed from a cohort of 137 patients showed high CD133 expression in 64% of stage I, 28% of stage II, and 54% of stage III tumors (29). Here, PROM1 is linked to colonic neoplasm.